Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyager™ DSLT, the first and only…
St, Judes Reports Promising results from first prenatal therapy for spinal muscular atrophy
On Feb. 19, 2025, scientists at St. Jude Children’s Research Hospital report results from a promising new approach…
Scientists Decode Diet From Stool DNA
On Feb. 18, 2025, scientists from the Institute for Systems Biology announced they have developed a breakthrough method…
Woman in cancer remission for record 19 years after CAR-T immune treatment
On Feb. 17, 2025, researchers from Texas Children’s Hospital in Houston announced that the four year old girl…
Researchers identify DNA changes, biological pathways associated with inherited cancer risk
On Feb. 17, 2025, Stanford researchers have conducted the first large-scale screen of these inherited changes, called single…
Next-gen Alzheimer’s drugs extend independent living by months
On Feb. 13, 2025, researchers at Washington University School of Medicine in St. Louis announced a new analysis…
Mechanism for treating muscle degeneration discovered
On Feb. 12, 2025, researchers at the Max Planck Institute released a study that could pave the way…
New blood test accurately predicts preeclampsia
On Feb. 12, 2025, a study led by researchers from the University of Washington announced that a new…
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy
On Feb. 12, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) has approved a New…
‘Junk’ RNA segments play role in protein production, cell stress response
On Feb. 11, 2025, scientists from Ohio State University (OSU) have discovered that some tiny segments of RNA…
Research shows path to easier diagnosis of mitochondrial disorders
On Feb. 11, 2025, in study of mitochondrial disease at the University of Alberta researcher revealed an easier…
man destined for early Alzheimer’s Survived More Than Twenty Years longer than expected
On Feb. 10, 2025, scientists announced identifying genetic variants that could have helped a man to avoid dementia…
Mutations in two gene pairs point to a promising drug target in 5 percent of adult cancers
On Feb. 5, 2025, scientists from the Cancer Dependency Map (DepMap) at the Broad Institute of MIT and…
Scientists Identify Alzheimer’s Disease-Protective Genetic Factors and Unravel Disease Mechanisms
On Feb. 4, 2025, an international research teams led by Hong Kong University of Science and Technology (HKUST)…
Biotechnology | Disease | FDA | Life Science News | Neurology | Ophthalmogy | Therapeutics
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
On Feb. 4, 2025, Genentech announced that the U.S. Food and Drug Administration (FDA) had approved Susvimo® (ranibizumab…
TGen researchers create spatial map of gene expression in pulmonary fibrosis
On Feb. 3, 2025, a team of researchers co-led by TGen, part of City of Hope announced creating…
United Therapeutics Announces FDA Clearance of Pig Transplantation Clinical Trial
On Feb. 3, 2025, United Therapeutics, a public benefit corporation, announced that the U.S.Food and Drug Administration (FDA)…
Biotechnology | Diagnostics | Disease | Life Science News | Neurology | Non-Profit Research | Therapeutics
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
On Jan. 30, 2025, the California Institute for Regenerative Medicine (CIRM) announced it has awarded nearly $100 million…
‘Breakthrough’ stem-cell patches strengthened a woman’s failing heart
On Jan. 29, 2025, researchers from the University Medical Center Göttingen announced they have shown that patches of…
FDA approves Ozempic® (semaglutide) as only GLP-1 RA to reduce the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and CKD
On Jan. 28, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) has approved Ozempic® to…
A genome-wide atlas of cell morphology revealed gene functions
On Jan. 27, 2025, researchers at the Broad Institute of MIT and Harvard, along with collaborators at Calico…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Medicine | Neurology | NIH | Oncology | Therapeutics | U.S. Congress | Vaccine | Women's Health
U.S. FDA drops Support improving clinical trial diversity
Jan. 24, 2025, the U.S. Food and Drug Administration (FDA) pulled draft guidance from its website requiring companies…
SIDS Discovery Could ID Babies at Risk
On Jan. 22, 2025, researchers from the University of Virginia School of Medicine reported revealing the fingerprints of…
PET probe images inflammation with high sensitivity and selectivity
On Jan. 22, 2025, researchers at Dana-Farber Cancer Institute announced they have developed a breakthrough method to detect…
FDA approved SPRAVATO® (esketamine) in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
On Jan. 21, 2025, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) approval of a…
huge study highlights new health risks of Obesity drugs
On Jan. 20, 2025, an analysis of data from nearly 2 million people has revealed new insights into…
Study pinpoints depression genes across ethnicities
On Jan. 14, 2025, an international research team led by the University of Edinburgh reported new genetic risk…
United States Dementia Cases Estimated to Double by 2060
On Jan. 13, 2025, a study led by NYU Langone Health shows that the risk of developing dementia at…
Research Highlights Trends in ADHD Diagnoses
On Jan. 13, 2025, new research identifies differing trends in attention-deficit/hyperactivity disorder (ADHD) diagnoses among adolescents and adults,…
University of Queensland manufactures 3D printed scaffolding to rebuild jaw bones
On Jan. 9, 2025, clinicians from the The University of Queensland (UQ) announced they had successfully used custom-made…